Janney Montgomery Scott LLC increased its holdings in American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 25.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,493 shares of the company’s stock after purchasing an additional 3,578 shares during the quarter. Janney Montgomery Scott LLC’s holdings in American Healthcare REIT were worth $530,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. GPS Wealth Strategies Group LLC grew its stake in American Healthcare REIT by 14.7% during the 1st quarter. GPS Wealth Strategies Group LLC now owns 72,905 shares of the company’s stock valued at $2,209,000 after acquiring an additional 9,336 shares in the last quarter. CX Institutional bought a new position in shares of American Healthcare REIT in the first quarter valued at approximately $155,000. Handelsbanken Fonder AB lifted its position in American Healthcare REIT by 32.5% during the 1st quarter. Handelsbanken Fonder AB now owns 51,400 shares of the company’s stock worth $1,557,000 after acquiring an additional 12,600 shares during the last quarter. GAMMA Investing LLC boosted its stake in American Healthcare REIT by 42.2% during the 1st quarter. GAMMA Investing LLC now owns 1,405 shares of the company’s stock valued at $43,000 after purchasing an additional 417 shares during the period. Finally, Wealthcare Advisory Partners LLC grew its stake in shares of American Healthcare REIT by 41.0% in the first quarter. Wealthcare Advisory Partners LLC now owns 13,718 shares of the company’s stock worth $416,000 after acquiring an additional 3,987 shares during the last quarter. Institutional investors and hedge funds own 16.68% of the company’s stock.
Insider Buying and Selling at American Healthcare REIT
In other news, CIO Stefan K.L. Oh sold 3,860 shares of the company’s stock in a transaction on Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the sale, the executive directly owned 95,671 shares in the company, valued at approximately $3,453,723.10. This represents a 3.88% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.92% of the company’s stock.
American Healthcare REIT Stock Up 0.4%
American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. American Healthcare REIT had a negative return on equity of 1.85% and a negative net margin of 1.96%. The firm had revenue of $540.60 million during the quarter, compared to the consensus estimate of $542.32 million. During the same period last year, the company earned $0.30 earnings per share. The business’s revenue was up 8.2% compared to the same quarter last year. As a group, equities research analysts predict that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.
American Healthcare REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.75%. The ex-dividend date of this dividend is Monday, June 30th. American Healthcare REIT’s dividend payout ratio is -370.37%.
Wall Street Analyst Weigh In
Several equities analysts have commented on AHR shares. Truist Financial upped their price target on American Healthcare REIT from $32.00 to $38.00 and gave the company a “buy” rating in a report on Monday, June 9th. Scotiabank started coverage on shares of American Healthcare REIT in a research note on Monday. They set a “sector outperform” rating and a $42.00 price objective on the stock. Jefferies Financial Group assumed coverage on American Healthcare REIT in a report on Monday, April 28th. They issued a “buy” rating and a $37.00 price target for the company. Morgan Stanley increased their price objective on American Healthcare REIT from $37.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, May 20th. Finally, KeyCorp raised their price objective on shares of American Healthcare REIT from $34.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday, June 11th. Nine equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $37.75.
View Our Latest Analysis on AHR
American Healthcare REIT Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles
- Five stocks we like better than American Healthcare REIT
- How to Short Nasdaq: An Easy-to-Follow Guide
- Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Whiplash for Investors: AeroVironment’s Confusing Stock Signals
- Want to Profit on the Downtrend? Downtrends, Explained.
- The Ultimate Trump Bump: These Gov’t Backed Stocks Are Exploding
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.